In addition, compared with normal tissues, IGF2BP3 was up-regulated in many tumors, including lung adenocarcinoma, ovarian cancer, breast invasive cancer, bladder urothelial carcinoma and so on (40). This evidence concerns the gene IGF2BP3 and ovarian carcinoma.